Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety

Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceuticals (Basel, Switzerland) Switzerland), 2020-02, Vol.13 (3), p.34, Article 34
Hauptverfasser: Shoda, Takuji, Ohoka, Nobumichi, Tsuji, Genichiro, Fujisato, Takuma, Inoue, Hideshi, Demizu, Yosuke, Naito, Mikihiko, Kurihara, Masaaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 34
container_title Pharmaceuticals (Basel, Switzerland)
container_volume 13
creator Shoda, Takuji
Ohoka, Nobumichi
Tsuji, Genichiro
Fujisato, Takuma
Inoue, Hideshi
Demizu, Yosuke
Naito, Mikihiko
Kurihara, Masaaki
description Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR.
doi_str_mv 10.3390/ph13030034
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3390_ph13030034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_eea8d0eaf35a447d86d0789256ee0c02</doaj_id><sourcerecordid>2369422466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</originalsourceid><addsrcrecordid>eNqNUsFu1DAQjRCIlsKFD0A-ItDCOHZi54JUhUIrLYJDOVuOPcm6SuLFdor27_F2y9LeuNijeW_ePPm5KF5T-MBYAx-3G8qAATD-pDilvOQrWXLx9EF9UryI8QagEpTT58UJKynUFYjTAq91GDChJT-CT-hm8hmHoK1Ozs-k25F24yYMzpDWT1u_zDaSJbp5IJc7G_x247uMXTCydoPeg_kg51ZPek56RvLNO0y7l8WzXo8RX93fZ8XPLxfX7eVq_f3rVXu-XpmKQlo1je2kEA3KHnTVaSHqEqjZd7GiNQrLKtrxDhspDTdgbCVBguhqrDWYmp0VVwdd6_WN2gY36bBTXjt11_BhUDokZ0ZUiFpaQN2zSnMurKwtCNmUVY0IBsqs9emgtV26Ca3BOQU9PhJ9jMxuowZ_qwTNXiVkgbf3AsH_WjAmNblocBzzu_glqpLVDS9LXu99vztQTfAxBuyPayiofcbqX8aZ_OahsSP1b6iZIA-E39j5PhqHs8EjDfI3KJkAwXNFRevSXdZtzjbl0ff_P8r-AOQqw0c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2369422466</pqid></control><display><type>article</type><title>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Shoda, Takuji ; Ohoka, Nobumichi ; Tsuji, Genichiro ; Fujisato, Takuma ; Inoue, Hideshi ; Demizu, Yosuke ; Naito, Mikihiko ; Kurihara, Masaaki</creator><creatorcontrib>Shoda, Takuji ; Ohoka, Nobumichi ; Tsuji, Genichiro ; Fujisato, Takuma ; Inoue, Hideshi ; Demizu, Yosuke ; Naito, Mikihiko ; Kurihara, Masaaki</creatorcontrib><description>Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph13030034</identifier><identifier>PMID: 32106507</identifier><language>eng</language><publisher>BASEL: Mdpi</publisher><subject>adamantane ; Chemistry, Medicinal ; chimeric compound ; hydrophobic tagging ; Life Sciences &amp; Biomedicine ; Pharmacology &amp; Pharmacy ; protein degradation ; Science &amp; Technology</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2020-02, Vol.13 (3), p.34, Article 34</ispartof><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>7</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000523707400017</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</citedby><cites>FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</cites><orcidid>0000-0003-0451-1337</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151680/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151680/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,28253,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32106507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shoda, Takuji</creatorcontrib><creatorcontrib>Ohoka, Nobumichi</creatorcontrib><creatorcontrib>Tsuji, Genichiro</creatorcontrib><creatorcontrib>Fujisato, Takuma</creatorcontrib><creatorcontrib>Inoue, Hideshi</creatorcontrib><creatorcontrib>Demizu, Yosuke</creatorcontrib><creatorcontrib>Naito, Mikihiko</creatorcontrib><creatorcontrib>Kurihara, Masaaki</creatorcontrib><title>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</title><title>Pharmaceuticals (Basel, Switzerland)</title><addtitle>PHARMACEUTICALS-BASE</addtitle><addtitle>Pharmaceuticals (Basel)</addtitle><description>Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR.</description><subject>adamantane</subject><subject>Chemistry, Medicinal</subject><subject>chimeric compound</subject><subject>hydrophobic tagging</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Pharmacology &amp; Pharmacy</subject><subject>protein degradation</subject><subject>Science &amp; Technology</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>DOA</sourceid><recordid>eNqNUsFu1DAQjRCIlsKFD0A-ItDCOHZi54JUhUIrLYJDOVuOPcm6SuLFdor27_F2y9LeuNijeW_ePPm5KF5T-MBYAx-3G8qAATD-pDilvOQrWXLx9EF9UryI8QagEpTT58UJKynUFYjTAq91GDChJT-CT-hm8hmHoK1Ozs-k25F24yYMzpDWT1u_zDaSJbp5IJc7G_x247uMXTCydoPeg_kg51ZPek56RvLNO0y7l8WzXo8RX93fZ8XPLxfX7eVq_f3rVXu-XpmKQlo1je2kEA3KHnTVaSHqEqjZd7GiNQrLKtrxDhspDTdgbCVBguhqrDWYmp0VVwdd6_WN2gY36bBTXjt11_BhUDokZ0ZUiFpaQN2zSnMurKwtCNmUVY0IBsqs9emgtV26Ca3BOQU9PhJ9jMxuowZ_qwTNXiVkgbf3AsH_WjAmNblocBzzu_glqpLVDS9LXu99vztQTfAxBuyPayiofcbqX8aZ_OahsSP1b6iZIA-E39j5PhqHs8EjDfI3KJkAwXNFRevSXdZtzjbl0ff_P8r-AOQqw0c</recordid><startdate>20200225</startdate><enddate>20200225</enddate><creator>Shoda, Takuji</creator><creator>Ohoka, Nobumichi</creator><creator>Tsuji, Genichiro</creator><creator>Fujisato, Takuma</creator><creator>Inoue, Hideshi</creator><creator>Demizu, Yosuke</creator><creator>Naito, Mikihiko</creator><creator>Kurihara, Masaaki</creator><general>Mdpi</general><general>MDPI</general><general>MDPI AG</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0451-1337</orcidid></search><sort><creationdate>20200225</creationdate><title>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</title><author>Shoda, Takuji ; Ohoka, Nobumichi ; Tsuji, Genichiro ; Fujisato, Takuma ; Inoue, Hideshi ; Demizu, Yosuke ; Naito, Mikihiko ; Kurihara, Masaaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>adamantane</topic><topic>Chemistry, Medicinal</topic><topic>chimeric compound</topic><topic>hydrophobic tagging</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Pharmacology &amp; Pharmacy</topic><topic>protein degradation</topic><topic>Science &amp; Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shoda, Takuji</creatorcontrib><creatorcontrib>Ohoka, Nobumichi</creatorcontrib><creatorcontrib>Tsuji, Genichiro</creatorcontrib><creatorcontrib>Fujisato, Takuma</creatorcontrib><creatorcontrib>Inoue, Hideshi</creatorcontrib><creatorcontrib>Demizu, Yosuke</creatorcontrib><creatorcontrib>Naito, Mikihiko</creatorcontrib><creatorcontrib>Kurihara, Masaaki</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shoda, Takuji</au><au>Ohoka, Nobumichi</au><au>Tsuji, Genichiro</au><au>Fujisato, Takuma</au><au>Inoue, Hideshi</au><au>Demizu, Yosuke</au><au>Naito, Mikihiko</au><au>Kurihara, Masaaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><stitle>PHARMACEUTICALS-BASE</stitle><addtitle>Pharmaceuticals (Basel)</addtitle><date>2020-02-25</date><risdate>2020</risdate><volume>13</volume><issue>3</issue><spage>34</spage><pages>34-</pages><artnum>34</artnum><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR.</abstract><cop>BASEL</cop><pub>Mdpi</pub><pmid>32106507</pmid><doi>10.3390/ph13030034</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-0451-1337</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1424-8247
ispartof Pharmaceuticals (Basel, Switzerland), 2020-02, Vol.13 (3), p.34, Article 34
issn 1424-8247
1424-8247
language eng
recordid cdi_crossref_primary_10_3390_ph13030034
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects adamantane
Chemistry, Medicinal
chimeric compound
hydrophobic tagging
Life Sciences & Biomedicine
Pharmacology & Pharmacy
protein degradation
Science & Technology
title Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A07%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeted%20Protein%20Degradation%20by%20Chimeric%20Compounds%20using%20Hydrophobic%20E3%20Ligands%20and%20Adamantane%20Moiety&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Shoda,%20Takuji&rft.date=2020-02-25&rft.volume=13&rft.issue=3&rft.spage=34&rft.pages=34-&rft.artnum=34&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph13030034&rft_dat=%3Cproquest_cross%3E2369422466%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2369422466&rft_id=info:pmid/32106507&rft_doaj_id=oai_doaj_org_article_eea8d0eaf35a447d86d0789256ee0c02&rfr_iscdi=true